Search results
Results From The WOW.Com Content Network
As of 2023, the Indian pharmaceutical industry is the world's 13th largest by value and third largest in the world by volume. [8] The industry produces over 60,000 generic drugs in different 60 therapeutic categories. [8] India's revenue from pharmaceutical exports was $25.3 billion in the 2022-2023 financial year. [7]
India Brand Equity Foundation (IBEF) is a Trust established by the Department of Commerce, Ministry of Commerce and Industry, Government of India. [1] IBEF's primary objective is to promote and create international awareness of the Made in India label in markets overseas and to facilitate the dissemination of knowledge of Indian products and services.
The UCPMP is an extension of the Uniform Code for Pharmaceuticals Marketing Practices 2015 (UCPMP 2015), which took effect on 1 January 2015.Although there were long-standing expectations that the 2015 Code would be legally enforced, it remained a voluntary guideline for pharmaceutical companies to follow in their marketing practices.
The campaign uses both India as market for products and services as well as a destination for investment. The federal government is spearheading the campaign. [1] [2] Amongst the leading organizations working on building Brand India is India Brand Equity Foundation (IBEF), an initiative of the Ministry of Commerce and Industry, Government of ...
On 18 April 2020, the government of India passed an order that would protect Indian companies from FDI during the pandemic. All countries sharing a land border with India would now face scrutiny from the Ministry of Commerce and Industry before any FDIs. [19] These changes were incorporated in the Consolidated FDI policy released on 28 October ...
The Indian Pharmaceutical Alliance (IPA) is an association of domestic Indian pharmaceutical companies. IPA was founded in August 1999 by Dilip G Shah and six Indian drugmakers: Cipla , Dr. Reddy's , Lupin , Piramal , Ranbaxy , and Wockhardt . [ 1 ]
Gujarat accounts for a minimum of 28% of India's pharma exports, with exports totalling $5.36bn in 2018–19, up from $4.83bn the previous year. The Indian pharma industry has bounced back with an estimated export value of $19.15bn in 2018–19, an increase of 10.85% over the previous year.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. [20] India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports.